
Fred Hutch Joins CERo Therapeutics Clinical Trial
The Seattle center joins a Phase 1 study testing the safety of the experimental CER-1236 therapy for blood cancers.
Live Poll
Is the pace of progress in developing new cancer treatments improving in your country?
